Answers are grounded in this paper and cite their sources.
The FINGER trial demonstrated that a multidomain lifestyle intervention benefits cognition in older adults at-risk of dementia, yet the underlying biological mechanisms remain unclear. We measured neurodegeneration-related proteins using the NULISAseq CNS disease panel in 1158 FINGER participants to investigate associations between circulating proteins, cognitive trajectories, and intervention response. Independent of the intervention, ten proteins spanning immune, neuronal, and metabolic processes were associated with poorer cognitive trajectories, with TREM2 among the strongest signals. The intervention led to changes in eight proteins, including CRH, IL-7 and MME. Eleven proteins modified the cognitive response to intervention, with KDR and CRH showing the strongest effect. Complementary Elastic Net analyses confirmed CRH, and further identified PTN and CCL2 as markers of intervention responsiveness. Additional proteins showed APOE ε4- and sex-specific associations with the intervention response. Together, these findings identify proteomic signatures of cognitive response that could inform precision dementia prevention.
No takes yet. Share an insight, caveat, or question.
Daniilidou et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: